XCE Tirzepatide LY3298176 - Pharmaceutical Grade Weight Loss Compound 87805-34-3

XCE Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This compound demonstrates superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists.

As a dual agonist, XCE Tirzepatide exhibits greater affinity for GIP receptors while maintaining significant activity at GLP-1 receptors. This unique pharmacological profile results in enhanced glycemic control and metabolic effects, making it a valuable compound for scientific investigation.

The white powder formulation of XCE Tirzepatide ensures stability and ease of handling for research applications. Proper storage conditions maintain the compound's integrity for extended periods, supporting long-term study requirements.

For research use only. Not for human consumption. This product is intended solely for laboratory investigation by qualified professionals.